The mechanism involves the induction of ferroptosis in breast cancer cells through the zinc finger protein an1 type domain 5 (ZFAND5)/ solute carrier family 3 member 2 (SLC3A2) pathway, increasing the concentration of ROS in tumor cells, and reducing the level of GSH248. Here, SLC3A2 is linked to neoplasm.